{"id":"https://openalex.org/W1965511684","doi":"https://doi.org/10.1111/j.1460-9568.2003.02961.x","title":"SR141716A reduces the reinforcing properties of heroin but not heroin\u2010induced increases in nucleus accumbens dopamine in rats","display_name":"SR141716A reduces the reinforcing properties of heroin but not heroin\u2010induced increases in nucleus accumbens dopamine in rats","alternate_titles":[],"publication_year":2003,"publication_date":"2003-12-01","ids":{"openalex":"https://openalex.org/W1965511684","doi":"https://doi.org/10.1111/j.1460-9568.2003.02961.x","mag":"1965511684","pmid":"https://pubmed.ncbi.nlm.nih.gov/14656311"},"language":"en","primary_location":{"id":"doi:10.1111/j.1460-9568.2003.02961.x","doi":"https://doi.org/10.1111/j.1460-9568.2003.02961.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1460-9568.2003.02961.x","pdf_url":null,"source":{"id":"https://openalex.org/S171130801","display_name":"European Journal of Neuroscience","issn_l":"0953-816X","issn":["0953-816X","1460-9568"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Neuroscience","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1965511684"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030374033","display_name":"St\u00e9phanie Caill\u00e9","orcid":"https://orcid.org/0000-0002-4906-3091","observed_orcids":["https://orcid.org/0000-0002-4906-3091"]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"St\u00e9phanie Caill\u00e9","raw_affiliation_strings":["Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA","institution_ids":["https://openalex.org/I123431417"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113597221","display_name":"Loren H. Parsons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Loren H. Parsons","raw_affiliation_strings":["Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA","institution_ids":["https://openalex.org/I123431417"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I123431417"],"apc_list":{"value":3560,"currency":"USD","value_usd":3560},"apc_paid":null,"fwci":2.0695,"has_fulltext":false,"cited_by_count":95,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.86174606,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"18","issue":"11","first_page":"3145","last_page":"3149"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6563000082969666,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6563000082969666,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.3246999979019165,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sr141716a","display_name":"SR141716A","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cb1-receptor-antagonist","display_name":"CB1 receptor antagonist","score":0.7789999842643738},{"id":"https://openalex.org/keywords/heroin","display_name":"heroin","score":0.7200000286102295},{"id":"https://openalex.org/keywords/drug-self-administration","display_name":"self-administration","score":0.777999997138977},{"id":"https://openalex.org/keywords/nucleus-accumbens-shell","display_name":"nucleus accumbens shell","score":0.8379999995231628},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.9570000171661377},{"id":"https://openalex.org/keywords/opioid-reward","display_name":"opioid reward","score":0.6589999794960022},{"id":"https://openalex.org/keywords/endocannabinoid-system","display_name":"endocannabinoid system","score":0.7799999713897705},{"id":"https://openalex.org/keywords/fixed-ratio-schedules","display_name":"fixed-ratio schedules","score":0.6079999804496765},{"id":"https://openalex.org/keywords/progressive-ratio-schedule","display_name":"progressive ratio schedule","score":0.8730000257492065},{"id":"https://openalex.org/keywords/microdialysis","display_name":"microdialysis","score":0.8970000147819519}],"concepts":[{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.8987575173377991},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.7047329545021057},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.6987786889076233},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5216346383094788},{"id":"https://openalex.org/C50156730","wikidata":"https://www.wikidata.org/wiki/Q3856966","display_name":"Microdialysis","level":3,"score":0.5163713693618774},{"id":"https://openalex.org/C2777650357","wikidata":"https://www.wikidata.org/wiki/Q1569460","display_name":"Mesolimbic pathway","level":5,"score":0.5151766538619995},{"id":"https://openalex.org/C2778555786","wikidata":"https://www.wikidata.org/wiki/Q7448011","display_name":"Self-administration","level":2,"score":0.47318410873413086},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42751482129096985},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.3751322329044342},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.36799949407577515},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.34072145819664},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2632019519805908},{"id":"https://openalex.org/C2780948874","wikidata":"https://www.wikidata.org/wiki/Q640562","display_name":"Ventral tegmental area","level":4,"score":0.17057311534881592},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.1053018569946289}],"mesh":[{"descriptor_ui":"D000077285","descriptor_name":"Rimonabant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001920","descriptor_name":"Bradykinin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D003932","descriptor_name":"Heroin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009714","descriptor_name":"Nucleus Accumbens","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009714","descriptor_name":"Nucleus Accumbens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012055","descriptor_name":"Reinforcement Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012646","descriptor_name":"Self Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017551","descriptor_name":"Microdialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1460-9568.2003.02961.x","doi":"https://doi.org/10.1111/j.1460-9568.2003.02961.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1460-9568.2003.02961.x","pdf_url":null,"source":{"id":"https://openalex.org/S171130801","display_name":"European Journal of Neuroscience","issn_l":"0953-816X","issn":["0953-816X","1460-9568"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Neuroscience","raw_type":"journal-article"},{"id":"pmid:14656311","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14656311","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The European journal of neuroscience","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W434697856","https://openalex.org/W1699530412","https://openalex.org/W1964909230","https://openalex.org/W1965679449","https://openalex.org/W1990042350","https://openalex.org/W1993599253","https://openalex.org/W2001865657","https://openalex.org/W2004927151","https://openalex.org/W2007251017","https://openalex.org/W2016430454","https://openalex.org/W2020291109","https://openalex.org/W2048756351","https://openalex.org/W2054203254","https://openalex.org/W2055207238","https://openalex.org/W2061265320","https://openalex.org/W2075734834","https://openalex.org/W2076413331","https://openalex.org/W2079311820","https://openalex.org/W2080835148","https://openalex.org/W2086781281","https://openalex.org/W2094296755","https://openalex.org/W2137134274","https://openalex.org/W2155900685","https://openalex.org/W2156255848","https://openalex.org/W2164726829","https://openalex.org/W2169863475","https://openalex.org/W2171065970","https://openalex.org/W2171584675","https://openalex.org/W2264748786"],"related_works":["https://openalex.org/W2103903337","https://openalex.org/W2004753631","https://openalex.org/W2012132003","https://openalex.org/W2153424052","https://openalex.org/W1976484066","https://openalex.org/W2811371444","https://openalex.org/W1964909230","https://openalex.org/W2114325644","https://openalex.org/W1699530412","https://openalex.org/W2092040369"],"abstract_inverted_index":{"The":[0],"present":[1],"experiments":[2],"tested":[3],"the":[4,7,49,75,106,126,137,150],"hypothesis":[5],"that":[6,70,97,136],"selective":[8],"CB1":[9,71,138],"receptor":[10,72],"antagonist":[11],"SR141716A":[12,25,92,116],"alters":[13],"heroin":[14,33,55,98,120,142],"self-administration":[15,34,99],"by":[16,35,85,90],"attenuating":[17],"heroin-induced":[18],"increases":[19,101],"in":[20,105,129,149],"nucleus":[21,107,130,151],"accumbens":[22,108,131,152],"dopamine":[23,103],"levels.":[24],"pretreatment":[26,117],"dose-dependently":[27,118],"(0.3-3":[28],"mg/kg,":[29],"i.p.)":[30],"reduced":[31,119],"operant":[32],"male":[36],"Wistar":[37],"rats":[38,87],"under":[39,56],"a":[40,57],"fixed":[41],"ratio":[42,59],"schedule":[43,60],"of":[44,52,61,78,110,141],"reinforcement,":[45],"and":[46],"significantly":[47,100],"lowered":[48],"breaking":[50],"point":[51],"responding":[53,81],"for":[54,82],"progressive":[58],"reinforcement.":[62],"These":[63,133],"observations":[64],"are":[65],"consistent":[66],"with":[67],"recent":[68],"reports":[69],"inactivation":[73],"reduces":[74],"rewarding":[76],"properties":[77],"opiates.":[79],"Operant":[80],"water":[83],"reinforcement":[84],"water-restricted":[86],"was":[88],"unaltered":[89],"these":[91],"doses.":[93],"Microdialysis":[94],"tests":[95],"revealed":[96],"interstitial":[102],"levels":[104],"shell":[109],"vehicle-pretreated":[111],"control":[112],"rats.":[113],"However,":[114],"whereas":[115],"self-administration,":[121],"it":[122],"did":[123],"not":[124,145],"alter":[125],"heroin-associated":[127],"increase":[128],"dopamine.":[132],"findings":[134],"suggest":[135],"antagonist-induced":[139],"attenuation":[140],"reward":[143],"does":[144],"involve":[146],"dopaminergic":[147],"mechanisms":[148],"shell.":[153]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1965511684","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
